CRISPR Therapeutics AG (CRSP) Institutional Ownership Changes & 13F Activity
CRISPR Therapeutics AG (CRSP). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include ARK Invest, T. Rowe Price Investment Management, Inc., D. E. Shaw & Co., Inc., Orbis Allan Gray Ltd, and Two Sigma Investments, Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Reynders Mcveigh Capital Management, Llc | Sell | -92,373 | -74.8% | 31,065 | $1.69K | Q2 2026 | Sep 15, 2026 |
| Manufacturers Life Insurance Company, The | Sell | -2,952 | -6.7% | 40,825 | $2.23M | Q2 2026 | Sep 09, 2026 |
| Integrated Wealth Concepts Llc | Sell | -46 | -0.9% | 5,007 | $273.08K | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -50,556 | -9.8% | 465,796 | $25.40M | Q2 2026 | Sep 02, 2026 |
| Cornerstone Financial Management Llc | Sell | -9 | -100.0% | 0 | $0.00 | Q2 2026 | Aug 28, 2026 |
| Corient Private Wealth Llc | Sell | -970 | -2.8% | 33,841 | $1.85M | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Sell | -3,064 | -3.0% | 98,168 | $5.35M | Q2 2026 | Aug 24, 2026 |
| Kingsview Wealth Management, Llc | Buy | +3,672 | — | 3,672 | $200.27K | Q2 2026 | Aug 19, 2026 |
| Mercer Global Advisors Inc | Buy | +1,846 | +13.6% | 15,408 | $840.35K | Q2 2026 | Aug 19, 2026 |
| Beacon Pointe Advisors, Llc | Sell | -778 | -6.4% | 11,307 | $616.66K | Q2 2026 | Aug 18, 2026 |
| Jefferies Financial Group Inc. | Buy | +24,001 | — | 24,001 | $1.31M | Q2 2026 | Aug 17, 2026 |
| Empowered Funds, Llc | Buy | +5,446 | — | 5,446 | $297.02K | Q2 2026 | Aug 17, 2026 |
| Equitable Holdings, Inc. | Buy | +4,050 | +33.0% | 16,341 | $891.24K | Q2 2026 | Aug 17, 2026 |
| Jacobs Equity Llc | Buy | +3,085 | +26.6% | 14,675 | $800.38K | Q2 2026 | Aug 17, 2026 |
| Transamerica Financial Advisors, Llc | Sell | -2 | -50.0% | 2 | $109.00 | Q2 2026 | Aug 17, 2026 |
| ARK Invest | Sell | -1,852,684 | -16.4% | 9,460,939 | $516.00M | Q2 2026 | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | Sell | -899,578 | -30.5% | 2,053,017 | $111.97M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +893,812 | — | 893,812 | $48.75M | Q2 2026 | Aug 14, 2026 |
| Orbis Allan Gray Ltd | Sell | -656,850 | -10.8% | 5,449,161 | $297.20M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +505,570 | +34.1% | 1,988,621 | $108.46M | Q2 2026 | Aug 14, 2026 |
| Logos Global Management Lp | Buy | +300,000 | — | 300,000 | $16.36M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +250,614 | — | 250,614 | $13.67M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +172,033 | +17.5% | 1,155,105 | $63.00M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -166,228 | -28.0% | 427,178 | $23.30M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -141,848 | -34.2% | 272,372 | $14.86M | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Buy | +133,214 | +86.7% | 286,789 | $15.64M | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Sell | -106,236 | -78.6% | 28,893 | $1.58M | Q2 2026 | Aug 14, 2026 |
| Legal & General Group Plc | Buy | +88,170 | +116.6% | 163,810 | $8.93M | Q2 2026 | Aug 14, 2026 |
| Credit Agricole S A | Buy | +85,930 | — | 85,930 | $4.69M | Q2 2026 | Aug 14, 2026 |
| Clough Capital Partners L P | Buy | +73,652 | +298.4% | 98,337 | $5.36M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about CRSP activity
Which institutional owners are buying CRSP?
Institutional owners buying CRSP include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CRSP activity?
"Buy" means an investor increased their reported position in CRSP compared to the prior reporting period. This reflects growing exposure to CRISPR Therapeutics AG (CRSP) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CRSP increasing?
Institutional interest in CRSP can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.